Company Overview and News

0
Dynacor Begins its Exploration Campaign at Tumipampa

2018-05-30 globenewswire
MONTRÉAL, May 30, 2018 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor or the Corporation) is pleased to report that it has begun its 2018 exploration campaign in the disseminated gold zone at Tumipampa.
DNGDF DNG

0
Dynacor lance sa campagne d’exploration à Tumipampa

2018-05-30 globenewswire
MONTRÉAL, 30 mai 2018 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor ou la Société) a le plaisir d’annoncer qu’elle vient de lancer sa campagne d’exploration de 2018 dans la zone d’or disséminé de Tumipampa.
DNGDF DNG

0
Dynacor produit 6 974 onces d’or en avril 2018

2018-05-22 globenewswire
MONTRÉAL, 22 mai 2018 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor ou la Société) a le plaisir de publier sa production d’or d’avril 2018.
DNGDF DNG

0
Dynacor Produces 6,974 oz of Gold in April 2018

2018-05-22 globenewswire
MONTREAL, May 22, 2018 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor or the Corporation) is pleased to report its April 2018 gold production.
DNGDF DNG

0
Q1-2018: Dynacor Reports Net Income of US $1.6 M

2018-05-16 globenewswire
MONTREAL, May 16, 2018 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor or the Corporation) a Corporation with gold and silver ore processing operations and exploration projects in Peru, has released its unaudited condensed consolidated financial statements and the management's discussion and analysis (“MD&A”) for the three-month period ended March 31, 2018.
DNGDF DNG

0
T1-2018 : Dynacor publie un résultat net de 1,6 M $

2018-05-16 globenewswire
MONTRÉAL, 16 mai 2018 (GLOBE NEWSWIRE) -- Mines d'or Dynacor inc. (« Dynacor » ou la « Société ») (TSX:DNG) (OTC:DNGDF) qui exerce des activités de traitement de minerai d’or et d’argent et détient des projets d’exploration minière au Pérou vient de déposer ses états financiers consolidés intermédiaires résumés non audités et son rapport de gestion pour la période de trois mois close le 31 mars 2018.
DNGDF DNG

0
Dynacor produit 6 876 onces d’or au mois de mars 2018

2018-04-19 globenewswire
MONTRÉAL, 19 avr. 2018 (GLOBE NEWSWIRE) -- Mines d’or Dynacor Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor ou la Société) a le plaisir d’annoncer sa production mensuelle pour le mois de mars 2018.
DNGDF DNG

0
Dynacor Produces 6,876 oz of Gold in March 2018

2018-04-19 globenewswire
MONTREAL, April 19, 2018 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor or the Corporation) is pleased to report its March 2018 gold production.
DNGDF DNG

0
Dynacor annonce une offre publique de rachat d’actions dans le cours normal des activités

2018-04-17 globenewswire
MONTRÉAL, 17 avr. 2018 (GLOBE NEWSWIRE) -- Mines d’or Dynacor Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor ou la Société) a le plaisir d’annoncer que la Bourse de Toronto (la « TSX ») a approuvé son offre publique de rachat d’actions dans le cours normal des activités (OPRA). En vertu de l’offre, Dynacor est autorisée à racheter, aux fins d’annulation, un maximum de 1 982 717 actions ordinaires, représentant 5% de ses actions ordinaires émises et en circulation en date du 10 avril 2018.
DNGDF DNG

0
Dynacor Announces Share Buy Back Program

2018-04-17 globenewswire
MONTREAL, April 17, 2018 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX:DNG) (OTC:DNGDF) (Dynacor or the Corporation) is pleased to announce that the Toronto Stock Exchange has approved the Corporation's request to establish a normal course issuer bid share buyback program, through which Dynacor may purchase, for cancellation, up to 1,982,717 or approximately 5% of its outstanding common shares as of April 10, 2018.
DNGDF DNG

0
Dynacor Ends 2017 Surpassing US $100 M in Sales and Reports a Net Income of US$ 3.8 M

2018-03-29 marketwired
MONTREAL, QUEBEC--(Marketwired - March 29, 2018) - Dynacor Gold Mines Inc. (TSX:DNG)(OTC:DNGDF) (Dynacor or the Corporation) a Corporation with gold and silver ore processing operations and exploration projects in Peru, has released its audited consolidated financial statements and the management's discussion and analysis (MD&A) for the year ended December 31, 2017.
DNGDF DNG

0
Dynacor Produces 6,636 Oz of Gold in February

2018-03-19 marketwired
MONTREAL, QUEBEC--(Marketwired - March 19, 2018) - Dynacor Gold Mines Inc. (TSX:DNG)(OTC:DNGDF) (Dynacor or the Corporation) is pleased to report its February 2018 gold production.
DNGDF DNG

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to TSX:DNG / Dynacor Gold Mines Inc on message board site Silicon Investor.

cjtrdng adtrdng
KDNG Daytradng 101... A place to ask simple questions.